p53 mutation as a genetic trait of typical medullary breast carcinoma

被引：52
作者：
de Cremoux, P
Salomon, AV
Liva, S
Dendale, R
Bouchind'homme, B
Martin, E
Sastre-Garau, X
Magdelenat, H
Fourquet, A
Soussi, T
机构：
[1] Inst Curie, Dept Pathol, F-75248 Paris 05, France
[2] Univ Paris 07, F-75221 Paris, France
[3] Inst Curie, Dept Translat Res, Paris, France
[4] Inst Curie, Dept Radiotherapy, Paris, France
[5] Inst Curie, CNRS, Unite Mixte Rech 218, F-75231 Paris, France
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1999年 / 91卷 / 07期
关键词：
D O I：
10.1093/jnci/91.7.641
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：641 / 643
页数：3
相关论文
共 23 条
[1]   PROGNOSTIC-SIGNIFICANCE OF TP53 ALTERATIONS IN BREAST-CARCINOMA [J].
ANDERSEN, TI ;
HOLM, R ;
NESLAND, JM ;
HEIMDAL, KR ;
OTTESTAD, L ;
BORRESEN, AL .
BRITISH JOURNAL OF CANCER, 1993, 68 (03) :540-548
[2]   COMPLETE SEQUENCING OF THE P53 GENE PROVIDES PROGNOSTIC INFORMATION IN BREAST-CANCER PATIENTS, PARTICULARLY IN RELATION TO ADJUVANT SYSTEMIC THERAPY AND RADIOTHERAPY [J].
BERGH, J ;
NORBERG, T ;
SJOGREN, S ;
LINDGREN, A ;
HOLMBERG, L .
NATURE MEDICINE, 1995, 1 (10) :1029-1034
[3]   p53 mutations in BRCA1-associated familial breast cancer [J].
Crook, T ;
Crossland, S ;
Crompton, MR ;
Osin, P ;
Gusterson, BA .
LANCET, 1997, 350 (9078) :638-639
[4]  
DOMAGALA W, 1993, AM J PATHOL, V142, P669
[5]  
Eisinger F, 1998, CANCER RES, V58, P1588
[6]   A SIMPLE P53 FUNCTIONAL ASSAY FOR SCREENING CELL-LINES, BLOOD, AND TUMORS [J].
FLAMAN, JM ;
FREBOURG, T ;
MOREAU, V ;
CHARBONNIER, F ;
MARTIN, C ;
CHAPPUIS, P ;
SAPPINO, AP ;
LIMACHER, JM ;
BRON, L ;
BENHATTAR, J ;
TADA, M ;
VAN MEIR, EG ;
ESTREICHER, A ;
IGGO, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :3963-3967
[7]  
GOH HS, 1995, CANCER RES, V55, P5217
[8]  
Lakhani SR, 1997, LANCET, V349, P1505
[9]  
MARCHETTI A, 1993, CANCER RES, V53, P4665
[10]  
MOORE OS, 1949, CANCER, V2, P635, DOI 10.1002/1097-0142(194907)2:4<635::AID-CNCR2820020411>3.0.CO
123